71 related articles for article (PubMed ID: 11366230)
1. Calanolide at UTMB.
Res Initiat Treat Action; 1999 Jan; 5(1):20. PubMed ID: 11366230
[TBL] [Abstract][Full Text] [Related]
2. Calanolide A: a natural non-nucleoside reverse transcriptase inhibitor.
Hanna L
BETA; 1999 Apr; 12(2):8-9. PubMed ID: 11366704
[TBL] [Abstract][Full Text] [Related]
3. Safety and pharmacokinetics of single doses of (+)-calanolide a, a novel, naturally occurring nonnucleoside reverse transcriptase inhibitor, in healthy, human immunodeficiency virus-negative human subjects.
Creagh T; Ruckle JL; Tolbert DT; Giltner J; Eiznhamer DA; Dutta B; Flavin MT; Xu ZQ
Antimicrob Agents Chemother; 2001 May; 45(5):1379-86. PubMed ID: 11302799
[TBL] [Abstract][Full Text] [Related]
4. Chemical library and structure-activity relationships of 11-demethyl-12-oxo calanolide A analogues as anti-HIV-1 agents.
Ma T; Liu L; Xue H; Li L; Han C; Wang L; Chen Z; Liu G
J Med Chem; 2008 Mar; 51(5):1432-46. PubMed ID: 18284187
[TBL] [Abstract][Full Text] [Related]
5. [Anti-HIV activities of HIV-1 reverse transcriptase inhibitor racemic 11-demethyl-calanolide A].
Peng ZG; Chen HS; Wang L; Liu G
Yao Xue Xue Bao; 2008 May; 43(5):456-60. PubMed ID: 18717330
[TBL] [Abstract][Full Text] [Related]
6. Anti-HIV natural product (+)-calanolide A is active against both drug-susceptible and drug-resistant strains of Mycobacterium tuberculosis.
Xu ZQ; Barrow WW; Suling WJ; Westbrook L; Barrow E; Lin YM; Flavin MT
Bioorg Med Chem; 2004 Mar; 12(5):1199-207. PubMed ID: 14980631
[TBL] [Abstract][Full Text] [Related]
7. Pyranocoumarins from tropical species of the genus Calophyllum: a chemotaxonomic study of extracts in the National Cancer Institute collection.
McKee TC; Covington CD; Fuller RW; Bokesch HR; Young S; Cardellina II JH; Kadushin MR; Soejarto DD; Stevens PF; Cragg GM; Boyd MR
J Nat Prod; 1998 Oct; 61(10):1252-6. PubMed ID: 9784162
[TBL] [Abstract][Full Text] [Related]
8. Recent progress in the development of coumarin derivatives as potent anti-HIV agents.
Yu D; Suzuki M; Xie L; Morris-Natschke SL; Lee KH
Med Res Rev; 2003 May; 23(3):322-45. PubMed ID: 12647313
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of HIV-1 reverse transcriptase and HIV-1 replication by Calophyllum coumarins and xanthones.
Dharmaratne HR; Tan GT; Marasinghe GP; Pezzuto JM
Planta Med; 2002 Jan; 68(1):86-7. PubMed ID: 11842340
[TBL] [Abstract][Full Text] [Related]
10. The role of Thr139 in the human immunodeficiency virus type 1 reverse transcriptase sensitivity to (+)-calanolide A.
Auwerx J; Rodríguez-Barrios F; Ceccherini-Silberstein F; San-Félix A; Velázquez S; De Clercq E; Camarasa MJ; Perno CF; Gago F; Balzarini J
Mol Pharmacol; 2005 Sep; 68(3):652-9. PubMed ID: 15961674
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of action and resistant profile of anti-HIV-1 coumarin derivatives.
Huang L; Yuan X; Yu D; Lee KH; Chen CH
Virology; 2005 Feb; 332(2):623-8. PubMed ID: 15680427
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility of HIV-2, SIV and SHIV to various anti-HIV-1 compounds: implications for treatment and postexposure prophylaxis.
Witvrouw M; Pannecouque C; Switzer WM; Folks TM; De Clercq E; Heneine W
Antivir Ther; 2004 Feb; 9(1):57-65. PubMed ID: 15040537
[TBL] [Abstract][Full Text] [Related]
13. Apricitabine: a nucleoside reverse transcriptase inhibitor for HIV infection.
Gaffney MM; Belliveau PP; Spooner LM
Ann Pharmacother; 2009 Oct; 43(10):1676-83. PubMed ID: 19737995
[TBL] [Abstract][Full Text] [Related]
14. Simple, short peptide derivatives of a sulfonylindolecarboxamide (L-737,126) active in vitro against HIV-1 wild type and variants carrying non-nucleoside reverse transcriptase inhibitor resistance mutations.
Silvestri R; Artico M; De Martino G; La Regina G; Loddo R; La Colla M; Mura M; La Colla P
J Med Chem; 2004 Jul; 47(15):3892-6. PubMed ID: 15239667
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and anti-HIV activity of GS-9148 (2'-Fd4AP), a novel nucleoside phosphonate HIV reverse transcriptase inhibitor.
Boojamra CG; Mackman RL; Markevitch DY; Prasad V; Ray AS; Douglas J; Grant D; Kim CU; Cihlar T
Bioorg Med Chem Lett; 2008 Feb; 18(3):1120-3. PubMed ID: 18164198
[TBL] [Abstract][Full Text] [Related]
16. Anti-HIV-1 limonoid: first isolation from Clausena excavata.
Sunthitikawinsakul A; Kongkathip N; Kongkathip B; Phonnakhu S; Daly JW; Spande TF; Nimit Y; Napaswat C; Kasisit J; Yoosook C
Phytother Res; 2003 Nov; 17(9):1101-3. PubMed ID: 14595596
[TBL] [Abstract][Full Text] [Related]
17. Vaccine to prevent AIDS.
Tyring S
Res Initiat Treat Action; 1999 Jan; 5(1):9-10. PubMed ID: 11366234
[TBL] [Abstract][Full Text] [Related]
18. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
[TBL] [Abstract][Full Text] [Related]
19. Do women respond differently to HIV therapy than men?
Newsline People AIDS Coalit N Y; 1998 Dec; ():31. PubMed ID: 11367087
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 resistance to first- and second-generation non-nucleoside reverse transcriptase inhibitors.
Ghosn J; Chaix ML; Delaugerre C
AIDS Rev; 2009; 11(3):165-73. PubMed ID: 19654858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
